Alcon Laboratories Inc
General
Total Cases163
Active Cases2
Patents3,072
Ratings
Experience
Grade
Trend
DCT
L4
E
PTAB
L5
E
CAFC
L4
D
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 10/31/24 | SO ORDERED, re [271] STIPULATION TO EXTEND TIME to file redacted versions of D.I. [241] , [254] , [260] , and [261] to November 6, 2024 filed by Padagis LLC, Padagis Israel Pharmaceuticals Ltd., Padagis US LLC. Signed by Judge William C. Bryson on 10/31/2024. (mpb) (Entered: 10/31/2024) | |
| 10/31/24 | SO ORDERED, re [271] STIPULATION TO EXTEND TIME to file redacted versions of D.I. [241] , [254] , [260] , and [261] to November 6, 2024 filed by Padagis LLC, Padagis Israel Pharmaceuticals Ltd., Padagis US LLC. Signed by Judge William C. Bryson on 10/31/2024. (mpb) (Entered: 10/31/2024) | |
| 10/31/24 | SO ORDERED, re [271] STIPULATION TO EXTEND TIME to file redacted versions of D.I. [241] , [254] , [260] , and [261] to November 6, 2024 filed by Padagis LLC, Padagis Israel Pharmaceuticals Ltd., Padagis US LLC. Signed by Judge William C. Bryson on 10/31/2024. (mpb) (Entered: 10/31/2024) | |
| 10/30/24 | STIPULATION TO EXTEND TIME to file redacted versions of D.I. 241, 254, 260, and 261 to November 6, 2024 - filed by Padagis Israel Pharmaceuticals Ltd., Padagis LLC, Padagis US LLC. (Phillips, John) (Entered: 10/30/2024) | |
| 10/30/24 | STIPULATION TO EXTEND TIME to file redacted versions of D.I. 241, 254, 260, and 261 to November 6, 2024 - filed by Padagis Israel Pharmaceuticals Ltd., Padagis LLC, Padagis US LLC. (Phillips, John) (Entered: 10/30/2024) | |
| 10/30/24 | STIPULATION TO EXTEND TIME to file redacted versions of D.I. 241, 254, 260, and 261 to November 6, 2024 - filed by Padagis Israel Pharmaceuticals Ltd., Padagis LLC, Padagis US LLC. (Phillips, John) (Entered: 10/30/2024) | |
| 10/30/24 | REDACTED VERSION of [255] Letter, by Padagis Israel Pharmaceuticals Ltd., Padagis LLC, Padagis US LLC. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3)(Haney, Megan) (Entered: 10/30/2024) | |
| 10/30/24 | REDACTED VERSION of [255] Letter, by Padagis Israel Pharmaceuticals Ltd., Padagis LLC, Padagis US LLC. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3)(Haney, Megan) (Entered: 10/30/2024) | |
| 10/30/24 | REDACTED VERSION of [255] Letter, by Padagis Israel Pharmaceuticals Ltd., Padagis LLC, Padagis US LLC. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3)(Haney, Megan) (Entered: 10/30/2024) | |
| 10/30/24 | REDACTED VERSION of [250] Letter, by Padagis Israel Pharmaceuticals Ltd., Padagis LLC, Padagis US LLC. (Attachments: # [1] Exhibit A, # [2] PTX-0055, # [3] PTX-0056, # [4] PTX-0108, # [5] PTX-0109)(Haney, Megan) (Entered: 10/30/2024) |